A detailed history of Catalytic Wealth Ria, LLC transactions in Amgen Inc stock. As of the latest transaction made, Catalytic Wealth Ria, LLC holds 4,244 shares of AMGN stock, worth $1.19 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
4,244
Previous 4,416 3.89%
Holding current value
$1.19 Million
Previous $1.38 Billion 0.89%
% of portfolio
0.24%
Previous 0.27%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$309.38 - $337.38 $53,213 - $58,029
-172 Reduced 3.89%
4,244 $1.37 Billion
Q2 2024

Jul 31, 2024

BUY
$262.75 - $319.31 $2,102 - $2,554
8 Added 0.18%
4,416 $1.38 Billion
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $931,096 - $1.12 Million
3,463 Added 366.46%
4,408 $1.25 Billion
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $241,636 - $272,594
945 New
945 $272 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Catalytic Wealth Ria, LLC Portfolio

Follow Catalytic Wealth Ria, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalytic Wealth Ria, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalytic Wealth Ria, LLC with notifications on news.